Tilray

The Canadian company Tilray founded in 2013 is engaged in cultivation, processing and distribution of hemp and products on its basis. It has a federal license for activities in the USA.

Tilray became the first legal supplier of medical marijuana from North America to Europe. By July, 2018 the company exports the products to Australia, New Zealand, Argentina, Chile, the Republic of South Africa and a number of the countries in the EU, including Germany and Croatia.

History

2020: Merge to producer of Aphria cannabis

In the middle of December, 2020 couple of Canadian companies on production of cannabis decided to integrate to become the world's largest producer of marijuana on sales volumes. The company merger of Aphria and Tilray will take place within the transaction with actions.

Under the terms of the agreement, shareholders of Aphria will receive 0.8381 shares Tilray for each ordinary share Aphria owned by them. Upon completion of the transaction shareholders of Aphria will own about 62% of issued shares of Tilray that will lead to the return acquisition of Tilray. The united company will work under the name Tilray, and its actions will be issued at the exchange under a ticker of TLRY. Aphria will become division of Tilray. The transaction is estimated at 5 billion Canadian dollars ($3.9 billion).

Merge of Tilray to producer of Aphria cannabis

The current chairman and the chief executive officer of Aphria Irwin Simon will undertake the same duties in the united company. Directors of Aphria will occupy seven of nine places in Board of Directors of the new company, and Tilray will receive two others.

The companies stated that for the last 12 months their comprehensive income would be $874 million, and the share of the Canadian market selling cannabis would make 17% - the highest among all licensed producers. Aphria and Tilray expect that the transaction will allow to save about $100 million in key areas, including cultivation and production, purchase of cannabis and products, sales and marketing and also corporate expenses.

They also reported that merge will allow the platform Aphria to provide in Leamington additional sales volume under the Tilray brand and will save Tilray from need to buy cannabis wholesale at other licensed producers. Besides, the Tilray enterprise in London, the Province of Ontario, will provide to Aphria excess capacities for increase in production, including corporate food and drinks.^[1]

2018: Entry into the exchange

On July 18, 2018 Tilray became the public company, having placed the shares on the Nasdaq exchange. This the first IPO producer of marijuana in the USA.

Within listing of Tilray attracted $153 million, having sold 9 million shares at the price of $17 apiece that above originally set diapazn in $14-16. About 6.5 million papers investors from the USA purchased, other 2.5 million — from Canada and other countries. The Privateer Holdings fund from Seattle remained the core shareholder of Tilray.

The producer of Tilray marijuana went public

In the first day of biddings of the stock Tilray rose in price more than half and reached a point in $26.21. It is successful to place securities of the company interest from investors helped. Listing in the USA will help  Tilray to draw attention of an investment community and to get access to the capital. 

It is much easier way to find the capital and to invest, – the portfolio managing director of Navy Capital Sean Stifel told, having added that the USA already began "institutionalize" investments in marijuana.

Tilray which is based in Canada went public a month later after in the country approved the bill of marijuana legalization. To full age Canadians permitted to buy up to 30 grams of marijuana and to grow up at home up to four bushes of hemp. Marijuana can be sold online, but it is impossible to extend in the same shops where tobacco and alcohol is implemented.^[2]

Notes